Mail & Guardian
Mail & Guardian
biovac institutelatest news & developments
The next three to five years will require the continent to ensure there is sustainable business beyond Covid-19.
ASPEN PHARMACARE

It’s doable: Africa wants 60% of locally manufactured vaccines by 2040

The next three to five years will require the continent to ensure there is sustainable business beyond Covid-19.

  • Marcia Zali
2 min read
The World Health Organisation has enlisted a team of South African researchers to produce a new mRNA Covid-19 vaccine, but with no recipe to follow, it’s not an easy task. (Photo by Patrick Hertzog/AFP via Getty Images)
AFRICA

South Africa at the start of a Covid-19 vaccine the world has never seen

The World Health Organisation has enlisted a team of South African researchers to produce a new mRNA Covid-19 vaccine, but with no recipe to follow, it’s not an easy task

  • Laura López González
7 min read
On trial: About 800 people are part of a coronavirus vaccine trial by pharmaceutical giant Pfizer, headed by Rhulani Nhlaniki in South Africa. (Paul Botes/M&G)
BIOVAC INSTITUTE

Q&A Sessions: ‘My north star is the patient’

Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela…

  • Eyaaz Matwadia
7 min read